Cardiology

HDL anti-inflammatory capacity was inversely associated with incident CVD and may serve as a good predictor of CV risk when added to established risk assessment tools, according to data published in Circulation.

Healio spoke with Taimur Sher, MBBS, MD, a hematologist, internist and oncologist at the Mayo Clinic Cancer and Multispecialty Amyloidosis Center, about the effects and potential intolerance issues of auto-hematopoietic stem cell transplantation in amyloid light chain (AL) amyloidosis patients.

Healio spoke with Taimur Sher, MBBS, MD, a hematologist, internist and oncologist at the Mayo Clinic Cancer and Multispecialty Amyloidosis Center, , on assessing the three most important factors in amyloid light chain (AL) amyloidosis patients and how relapses can guide treatment paths.

Healio spoke with Taimur Sher, MBBS, MD, a hematologist, internist and oncologist at the Mayo Clinic Cancer and Multispecialty Amyloidosis Center, about approaches to care in amyloid light chain (AL) amyloidosis and the future of monoclonal antibodies in treatment.

Cardiovascular and hematological risk factors increased the risk for in-hospital mortality by 613% and 336%, respectively, in pediatric patients who had an ischemic stroke.

The cardiology profession has responded strongly to previous world crises and will do the same for the COVID-19 pandemic, American College of Cardiology president Richard J. Kovacs, MD, FACC, said at the opening of the society’s virtual Scientific Session.

Women continue to be the minority in training within the cardiology field and its subspecialties with minimal change during the past 10 years, according to a research letter published in Circulation.

Over a 25-year period, the number of women enrolled in internal medicine residencies increased, but the prevalence of women in subspecialty fellowships decreased, according to research published in JAMA Internal Medicine.

Top stories in cardiology last week included a study that found an association between fluoroquinolones and increased risks for aortic and mitral regurgitation, and the announcement that new Apple Watch studies will focus on cardiovascular health, women’s health, and hearing.

Cardiology Today and Healio spoke with several prominent cardiologists active in diversity and inclusion issues about their reactions to the news from The Lancet and where the cardiology specialty currently stands on diversity and inclusion.